Archives by Month:
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
Irma To Become A Major Hurricane Shortly, But Energy Markets Rightly Focus Elsewhere
The tropics certainly are active right now. Yesterday we had Tropical Storm Irma form, and now today it is already a hurricane. The storm is still forecast to take a rather unusual west-southwest track across the Atlantic, and this puts the United States at an elevated risk of landfall as it is less likely that […]
Emulating Endowments With ETFs
ETF.com posted an interview with Hossein Kazemi from Chartered Alternative Investment Analyst Association who did a study that concluded that small and medium sized endowments can effectively compete with the larger endowments by using ETFs to replicate the non-market based alternative strategies that funds like Harvard and Yale are known for and getting very similar return streams […]
Looming American Debt Ceiling Crisis
The U.S. government is getting closer and closer to running out of cash… for real this time. The government has until the end of September to raise the U.S. debt ceiling – that is, the total amount the government is allowed to borrow. Otherwise, it won’t be able to pay its bills. The U.S. government […]
Novartis (NVS) CAR-T Therapy Kymriah Receives FDA Approval
Novartis AG (NVS – Free Report) announced that the FDA has approved its breakthrough gene transfer treatment, Kymriah (tisagenlecleucel) suspension for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse. Kymriah, formerly CTL019, is the first chimeric antigen receptor T cell […]
3 Canadian Licensed Producers Capitalizing On Cannabis Oil
Cannabis oil is a significant revenue stream for licensed producers in Canada and this is a trend we expect to continue for the foreseeable future. Cannabis oil represents a fantastic opportunity and solution for licensed producers. The opportunity is great because not only does the product generate more revenue for the company but it also […]
The Big Four Economic Indicators: Real Personal Income In July
Note: This commentary has been updated to include this morning’s release of the July data for Real Personal Income Less Transfer Receipts. Official recession calls are the responsibility of the NBER Business Cycle Dating Committee, which is understandably vague about the specific indicators on which they base their decisions. This committee statementis about as close as they […]
Behold The Rulers
These are stocks which basically seem to go up pretty much forever, irrespective of… anything. It makes me wonder why there’s an entire industry of financial professionals and advisors (to say nothing of financial bloggers like myself) when it seems everyone could just dump everything into securities like those shown below (click on any of […]
Proving Q2 GDP The Anomaly, Incomes Yet Again Fail To Accelerate
One day after reporting a slightly better number for Q2 GDP, the BEA reports today that there is little reason to suspect it was anything more or lasting. The data for Personal Income and Spending shows that the dominant condition since 2012 remains in effect – “good” quarters, or whatever passes for one these days, […]
Market Valuation Continues To Decline
We now calculate that 52.16% of the stocks to which we can assign a valuation are overvalued and 19.68% of those stocks are overvalued by 20% or more. These numbers have declined fairly significantly below what we saw when we published our last valuation study in June. At that time, we saw an overvaluation figure […]
